Profile
James Wooldridge is currently the Chief Medical Officer at Checkmate Pharmaceuticals, Inc. He previously worked as the Chief Medical Officer at Spyre Therapeutics, Inc. from 2017 to 2019 and as the Chief Scientific Officer at Eli Lilly & Co. He received his doctorate degree from Tulane University in 1992 and his undergraduate degree from William Jewell College in 1988.
James Wooldridge active positions
| Companies | Position | Start |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-09-30 |
Former positions of James Wooldridge
| Companies | Position | End |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-10-09 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Training of James Wooldridge
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
William Jewell College
William Jewell College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- James Wooldridge
















